Perinatal Guidelines Update
November 17, 2005
The "Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States" have been revised to include:
Updates to Clinical Scenario #3. The new information discusses a 3- to 7-day "tail" of postpartum maternal ZDV/3TC following single dose maternal/infant nevirapine; this "tail" may reduce the risk of nevirapine resistance.
Updated information appears highlighted in yellow.
You can download the updated guidelines, or request to receive them by e-mail or hard copy from the AIDSinfo Web site.
The AIDSinfo Web site is also a useful source of other information related to HIV/AIDS, including other treatment and prevention guidelines, downloadable databases for PDAs (Personal Digital Assistants), fact sheets and HIV/AIDS-related clinical trials information.
This article was provided by U.S. Food and Drug Administration. Visit the FDA's website to find out more about their activities and publications.